Pediatrix Medical Group, Inc. Net Cash Provided by (Used in) Financing Activities in USD from Q1 2010 to Q1 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
Pediatrix Medical Group, Inc. quarterly/annual Net Cash Provided by (Used in) Financing Activities history and growth rate from Q1 2010 to Q1 2025.
  • Pediatrix Medical Group, Inc. Net Cash Provided by (Used in) Financing Activities for the quarter ending March 31, 2025 was -$6.04M, a 108% decline year-over-year.
  • Pediatrix Medical Group, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2024 was -$14.5M, a 43.7% increase from 2023.
  • Pediatrix Medical Group, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2023 was -$25.7M, a 94.7% increase from 2022.
  • Pediatrix Medical Group, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2022 was -$488M, a 35.9% increase from 2021.
Net Cash Provided by (Used in) Financing Activities, Quarterly (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Quarterly Growth (%)
Net Cash Provided by (Used in) Financing Activities, Annual (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Annual Growth (%)

Pediatrix Medical Group, Inc. Quarterly Net Cash Provided by (Used in) Financing Activities (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2025 -$6.04M -$82.2M -108% Jan 1, 2025 Mar 31, 2025 10-Q 2025-05-06
Q1 2024 $76.2M -$32.4M -29.8% Jan 1, 2024 Mar 31, 2024 10-Q 2025-05-06
Q1 2023 $109M +$365M Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-07
Q1 2022 -$256M +$505M +66.3% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-02
Q1 2021 -$762M -$1.13B -308% Jan 1, 2021 Mar 31, 2021 10-Q 2022-04-28
Q1 2020 $366M +$299M +449% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-07
Q1 2019 $66.7M -$49.9M -42.8% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-07
Q1 2018 $117M Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-02
Q1 2013 $47.2M -$18.1M -27.8% Jan 1, 2013 Mar 31, 2013 10-Q 2013-05-02
Q1 2012 $65.3M +$29M +79.7% Jan 1, 2012 Mar 31, 2012 10-Q 2012-05-03
Q1 2011 $36.3M -$46.2M -56% Jan 1, 2011 Mar 31, 2011 10-Q 2012-05-03
Q1 2010 $82.5M Jan 1, 2010 Mar 31, 2010 10-Q 2011-05-03

Pediatrix Medical Group, Inc. Annual Net Cash Provided by (Used in) Financing Activities (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 -$14.5M +$11.2M +43.7% Jan 1, 2024 Dec 31, 2024 10-K 2025-02-20
2023 -$25.7M +$462M +94.7% Jan 1, 2023 Dec 31, 2023 10-K 2025-02-20
2022 -$488M +$273M +35.9% Jan 1, 2022 Dec 31, 2022 10-K 2025-02-20
2021 -$760M -$756M -18181% Jan 1, 2021 Dec 31, 2021 10-K 2024-02-20
2020 -$4.16M +$389M +98.9% Jan 1, 2020 Dec 31, 2020 10-K 2023-02-17
2019 -$393M -$222M -130% Jan 1, 2019 Dec 31, 2019 10-K 2022-02-17
2018 -$171M -$260M -290% Jan 1, 2018 Dec 31, 2018 10-K 2021-02-18
2017 $89.7M -$292M -76.5% Jan 1, 2017 Dec 31, 2017 10-K 2020-02-20
2016 $382M Jan 1, 2016 Dec 31, 2016 10-K 2019-02-14
2013 -$132M -$270M -195% Jan 1, 2013 Dec 31, 2013 10-K 2014-02-12
2012 $138M +$226M Jan 1, 2012 Dec 31, 2012 10-K 2014-02-12
2011 -$87.8M -$209M -173% Jan 1, 2011 Dec 31, 2011 10-K 2014-02-12
2010 $121M Jan 1, 2010 Dec 31, 2010 10-K 2013-02-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.